[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07698483":3,"trial-entities:NCT07698483":125,"trial-summary:NCT07698483":128},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":23,"study_type":32,"primary_purpose":33,"phases":34,"enrollment_info":36,"interventions":39,"primary_outcomes":46,"secondary_outcomes":57,"sex":77,"minimum_age":78,"maximum_age":79,"healthy_volunteers":80,"eligibility_criteria":81,"std_ages":89,"locations":92,"central_contacts":113,"overall_officials":120,"references":123,"see_also_links":124},"NCT07698483","26-6387","DE-RESTRICT: Deimplementing Activity Restriction for Preterm Birth Prevention","Deimplementation of Activity Restriction for Preterm Birth Prevention in High-Risk Pregnancy (DE-RESTRICT): A Pilot Single-Arm Hybrid Effectiveness-Deimplementation Trial","NOT_YET_RECRUITING","2027-08-31","2026-07","2026-07-13","2026-07-01","University of Pennsylvania","OTHER",false,"DE-RESTRICT is a pilot study testing whether a strategy to reduce the use of activity restriction and bedrest in pregnancy is acceptable, appropriate, and feasible for prenatal care providers, and whether it changes how often activity restriction is recommended. Activity restriction and bedrest are commonly advised to try to prevent preterm birth, but they do not prevent it and may cause harm, and national guidelines recommend against them. The study takes place at two prenatal care settings within one health system and unfolds across four periods. In the pre-deimplementation period the study team develops a local clinical guideline and measures baseline outcomes. In the run-in period most provider education is delivered through interactive sessions with feedback, and audit and feedback begins. In the maintenance period audit and feedback continues. In the post-deimplementation period audit and feedback continues and outcomes are measured again. The study measures provider acceptability, appropriateness, and feasibility, the rate of activity restriction recommendations, patient-reported wellbeing and care experience, and the preterm birth rate.","This pilot single-arm hybrid effectiveness-deimplementation trial evaluates a multicomponent strategy to deimplement activity restriction and bedrest prescribed for preterm birth prevention among prenatal care providers and patients at high risk for preterm birth. All participating practices receive the strategy; there is no control arm. The strategy comprises a locally developed clinical guideline aligning with national recommendations, interactive provider education with feedback, and audit and feedback on the rate of activity restriction recommendations.\n\nThe four periods are sequential. The guideline is developed during the pre-deimplementation period, when baseline outcomes are also measured. Most provider education is delivered during the run-in period through interactive educational sessions with feedback, and audit and feedback begins. Audit and feedback continues through the maintenance and post-deimplementation periods. Outcomes are measured in the pre-deimplementation and post-deimplementation periods, and the rate of activity restriction recommendations is tracked continuously through an existing clinical text-messaging platform to support audit and feedback.\n\nPrimary outcomes are provider-reported acceptability, appropriateness, and feasibility. Secondary outcomes are the penetration of activity restriction recommendations and patient-reported outcomes. The preterm birth rate is an exploratory outcome. Analyses compare the pre-deimplementation and post-deimplementation periods, with nonresponse weighting and adjustment for patient age, race, parity, and qualifying diagnosis, and a hospital by period interaction for hospital-level estimates.",[19,20,21,22],"Preterm Birth","Activity Restriction","Bed Rest","Low-Value Care",[24,25,26,27,28,29,30,31],"deimplementation","low-value care","activity restriction","bedrest","preterm birth","audit and feedback","implementation science","hybrid trial","INTERVENTIONAL","HEALTH_SERVICES_RESEARCH",[35],"NA",{"count":37,"type":38},237,"ESTIMATED",[40],{"type":41,"name":42,"description":43,"armGroupLabels":44},"BEHAVIORAL","Multicomponent deimplementation strategy","A multicomponent strategy to reduce provider-recommended activity restriction and bedrest for preterm birth prevention, comprising development of a local clinical guideline aligned with national recommendations and identification of site champions; interactive educational sessions for providers with feedback; periodic audit and feedback to practices on the rate of activity restriction recommendations; and patient educational materials on safe physical activity in pregnancy that are made available to clinicians, who may choose to share them with patients. Delivered across the run-in, maintenance, and post-deimplementation periods and linked to the single study arm.",[45],"Deimplementation strategy",[47,51,54],{"measure":48,"description":49,"timeFrame":50},"Acceptability of Intervention Measure (AIM)","Mean provider score on the 4-item AIM, 5-point scale; higher scores indicate greater acceptability of the deimplementation strategy.","Post-deimplementation period (approximately months 13 to 14)",{"measure":52,"description":53,"timeFrame":50},"Intervention Appropriateness Measure (IAM)","Mean provider score on the 4-item IAM, 5-point scale; higher scores indicate greater perceived appropriateness.",{"measure":55,"description":56,"timeFrame":50},"Feasibility of Intervention Measure (FIM)","Mean provider score on the 4-item FIM, 5-point scale; higher scores indicate greater perceived feasibility.",[58,62,65,68,71,74],{"measure":59,"description":60,"timeFrame":61},"Penetration of activity restriction recommendations","Proportion of patients enrolled in THEA who, at 33 weeks, report a provider recommendation for activity restriction or bedrest, measured through the clinical text-messaging platform.","Change from pre-deimplementation (months 0 to 2) to post-deimplementation (months 13 to 14)",{"measure":63,"description":64,"timeFrame":61},"Generalized anxiety (GAD-7)","Patient score on the GAD-7.",{"measure":66,"description":67,"timeFrame":61},"Depressive symptoms (EPDS)","Patient score on the Edinburgh Postnatal Depression Scale.",{"measure":69,"description":70,"timeFrame":61},"Perceived stress (PSS-10)","Patient score on the Perceived Stress Scale.",{"measure":72,"description":73,"timeFrame":61},"Patient and clinician relationship (PDRQ-9)","Patient score on the Patient Doctor Relationship Questionnaire.",{"measure":75,"description":76,"timeFrame":61},"Quality of prenatal care (QPCQ)","Patient score on the Quality of Prenatal Care Questionnaire across its six subscales.","ALL","18 Years",null,true,{"inclusion":82,"exclusion":85,"raw_text":88},[83,84],"For Providers: Physicians, midwives, physician assistants, nurse practitioners, nurses, nursing assistants, medical assistants, and other healthcare staff who provide or participate in prenatal or high-risk pregnancy care or consultation at a participating site.","For Patients: Secondary patient-reported outcomes draw on pregnant individuals at high risk for preterm birth (qualifying diagnoses include short cervix, cervical insufficiency, multiple gestation, preterm labor, preterm contractions, vaginal bleeding, placental conditions, or a history of prior preterm birth), between 0 and 12 weeks postpartum for the survey measures. The activity restriction recommendation measure is collected through the Take Home Electronic Assessment (THEA) and therefore reaches only patients enrolled in THEA, at 33 weeks of gestation, across all periods; in the pre-deimplementation and post-deimplementation periods the additional survey battery is sent only to patients with a qualifying high-risk diagnosis.",[86,87],"For Providers: Staff who self-exclude by choosing not to interact with deimplementation meetings and communications","For Patients: Patients are excluded if they are unable to walk or are hospitalized without discharge home before delivery after the qualifying diagnosis is made.","Inclusion Criteria:\n\n* For Providers: Physicians, midwives, physician assistants, nurse practitioners, nurses, nursing assistants, medical assistants, and other healthcare staff who provide or participate in prenatal or high-risk pregnancy care or consultation at a participating site.\n* For Patients: Secondary patient-reported outcomes draw on pregnant individuals at high risk for preterm birth (qualifying diagnoses include short cervix, cervical insufficiency, multiple gestation, preterm labor, preterm contractions, vaginal bleeding, placental conditions, or a history of prior preterm birth), between 0 and 12 weeks postpartum for the survey measures. The activity restriction recommendation measure is collected through the Take Home Electronic Assessment (THEA) and therefore reaches only patients enrolled in THEA, at 33 weeks of gestation, across all periods; in the pre-deimplementation and post-deimplementation periods the additional survey battery is sent only to patients with a qualifying high-risk diagnosis.\n\nExclusion Criteria:\n\n* For Providers: Staff who self-exclude by choosing not to interact with deimplementation meetings and communications\n* For Patients: Patients are excluded if they are unable to walk or are hospitalized without discharge home before delivery after the qualifying diagnosis is made.",[90,91],"ADULT","OLDER_ADULT",[93,107],{"facility":94,"city":95,"state":96,"zip":97,"country":98,"contacts":99,"geoPoint":104},"Hospital of the University of Pennsylvania","Philadelphia","Pennsylvania","19104","United States",[100],{"name":101,"role":102,"email":103},"Beth L Pineles, MD, PhD","CONTACT","Beth.Pineles@Pennmedicine.upenn.edu",{"lat":105,"lon":106},39.95238,-75.16362,{"facility":108,"city":95,"state":96,"zip":109,"country":98,"contacts":110,"geoPoint":112},"Pennsylvania Hospital","19107",[111],{"name":101,"role":102,"email":103},{"lat":105,"lon":106},[114,117],{"name":115,"role":102,"phone":116,"email":103},"Beth Pineles, MD, PhD","267-283-8210",{"name":118,"role":102,"email":119},"Kelli Jackson","Kelli.Jackson@PennMedicine.upenn.edu",[121],{"name":101,"affiliation":13,"role":122},"PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":126,"biomarkers":127},[19],[],{"nct_id":4,"found":80,"summary":129,"prompt_version":139},{"design":130,"status":131,"heading":132,"summary":133,"follow_up":134,"word_count":135,"commitments":136,"compensation":137,"drugs_mentioned":138},"This is a single-arm study, meaning all participating healthcare practices will receive the new strategy; there is no comparison group. The study will involve approximately 237 participants.","completed","DE-RESTRICT: Reducing Activity Restriction for Preterm Birth Prevention","This study, called DE-RESTRICT, is testing a new approach to help doctors and other healthcare providers reduce recommendations for activity restriction and bed rest during pregnancy. These recommendations are often given to prevent preterm birth (when a baby is born too early), but national guidelines suggest they don't work and might even cause harm. The study is evaluating a \"multicomponent deimplementation strategy\" which includes new guidelines and educational sessions for providers. Researchers want to see if this strategy is acceptable, appropriate, and feasible for providers, and if it changes how often they recommend activity restriction. The study aims to enroll 237 participants, who are healthcare providers. The current status of the study is unclear.","Outcomes will be measured in the post-deimplementation period, which is approximately 13 to 14 months after the strategy is introduced.",114,"Not specified in the trial record.","Not stated in the trial record.",[42],"v2"]